Chugai Pharmaceutical Co., Ltd. (CHGCF)
42.88
+0.47
(+1.11%)
USD |
OTCM |
Aug 26, 16:00
Chugai Pharmaceutical EPS Diluted (Quarterly) : 0.4436 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4436 |
| March 31, 2026 | 0.447 |
| December 31, 2025 | 0.5064 |
| September 30, 2025 | 0.4584 |
| June 30, 2025 | 0.4084 |
| March 31, 2025 | 0.3877 |
| December 31, 2024 | 0.3651 |
| September 30, 2024 | 0.4458 |
| June 30, 2024 | 0.4362 |
| March 31, 2024 | 0.3045 |
| December 31, 2023 | 0.3748 |
| September 30, 2023 | 0.3261 |
| June 30, 2023 | 0.3676 |
| March 31, 2023 | 0.3374 |
| December 31, 2022 | 0.4404 |
| September 30, 2022 | 0.2979 |
| June 30, 2022 | 0.3388 |
| March 31, 2022 | 0.6886 |
| December 31, 2021 | 0.5283 |
| September 30, 2021 | 0.4749 |
| June 30, 2021 | 0.393 |
| March 31, 2021 | 0.2716 |
| December 31, 2020 | 0.3043 |
| September 30, 2020 | 0.3444 |
| June 30, 2020 | 0.2869 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2875 |
| December 31, 2019 | 0.2246 |
| September 30, 2019 | 0.2727 |
| June 30, 2019 | 0.1893 |
| March 31, 2019 | 0.1934 |
| December 31, 2018 | 0.1194 |
| September 30, 2018 | 0.1182 |
| June 30, 2018 | 0.1158 |
| March 31, 2018 | 0.1567 |
| December 31, 2017 | 0.0836 |
| September 30, 2017 | 0.1157 |
| June 30, 2017 | 0.0964 |
| March 31, 2017 | 0.0992 |
| December 31, 2016 | 0.0584 |
| September 30, 2016 | 0.0687 |
| June 30, 2016 | 0.0963 |
| March 31, 2016 | 0.0767 |
| December 31, 2015 | 0.0677 |
| September 30, 2015 | 0.0873 |
| June 30, 2015 | 0.0781 |
| March 31, 2015 | 0.0746 |
| December 31, 2014 | 0.06 |
| September 30, 2014 | 0.0636 |
| June 30, 2014 | 0.0605 |
| March 31, 2014 | 0.1116 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Eisai Co., Ltd. | 0.1015 |
| Santen Pharmaceutical Co., Ltd. | 0.1399 |
| Ono Pharmaceutical Co., Ltd. | 0.1075 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 730.02M |
| Revenue (Quarterly) | 2.144B |
| Total Expenses (Quarterly) | 1.414B |
| Enterprise Value | 64.74B |
| Gross Profit Margin (Quarterly) | 69.49% |
| Profit Margin (Quarterly) | 34.06% |
| Earnings Yield | 4.33% |
| Operating Earnings Yield | 6.22% |
| Normalized Earnings Yield | 4.532 |